EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

Market Cap	44.44B -29.8%
Revenue (ttm)	9.32B -19.2%
Net Income	-2.32B
EPS	-3.38
Shares Out	685.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	1.49 (2.35%)
Ex-Dividend Date	May 6, 2026

Volume	2,079,801
Open	64.35
Previous Close	64.85
Day's Range	63.50 - 65.25
52-Week Range	54.80 - 132.60
Beta	0.28
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 28, 2026

About IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment engages in development of real estate properties; rental activities for serum facilities; and providing consulting services on land development and project management. The company was incorpo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 904
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2025, IST:ECILC's revenue was 9.87 billion, a decrease of -13.98% compared to the previous year's 11.48 billion. Earnings were 2.09 billion, an increase of 55.90%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error